Archive for the ‘Biotech investment India’ Category

Strides Arcolab Limited enters agreement to acquire 70 per cent of the Bangalore based biotechnology firm Inbiopro Solutions

Comments Off | 12-11-2010

Strides Arcolab Limited Thursday announced it had entered into an agreement to acquire 70% stake in Bangalore-based biotechnology firm, Inbiopro Solutions. The acquisition marks Strides Arcolab’s foray into biologics. The move is aimed at strengthening the Company’s offering in the Specialty segment. The investment also gives Strides immediate access to a pipeline of 8 products

Tags: , , , , , , , , , , ,
Posted in Biotech investment India, FDI news India, General | Read More

Indian biotechnology company Transgene Biotek Ltd to raise Rs. 500 Crore via GDRs/ADRs and other securities

Comments Off | 11-9-2010

Indian biotechnology company Transgene Biotek reported its planning to raise funds for financing its aggressive expansion strategy. Transgene said it had settled on raising funds from either international markets through issue of equity shares, FCCBs, GDRs, ADRs and or other securities inclusive of debt instruments or from local offerings via FPO, Preferential issue, Rights issue

Tags: , , , , , , , , , , ,
Posted in Biotech investment India, FDI news India, General | Read More

American based biotechnology company Life Technologies to acquire unit of its distributor firm Labindia

Comments Off | 11-3-2010

Life Technologies, the American based biotechnology company Tuesday reported it is to acquire a unit of its Indian distributor firm, Labindia through its wholly-owned Indian subsidiary Invitrogen BioServices India Pvt Ltd.
However, the amount involved in the transaction was not revealed. Labindia distributes the US firm’s products in India, and a statement from Life Technologies said

Tags: , , , , , , , , , , ,
Posted in Biotech investment India, FDI Regulations in India, FDI news India, General | Read More

Cipla announces investment worth $65 million (Rs.300 crore) to acquire stakes in MabPharm & BioMab

Comments Off | 06-16-2010

Cipla announced an investment of $65 million, about Rs 300 crore, for the acquisition of stakes in 2 (Indian and Chinese) Biotechnology companies on Tuesday. With the investment in the two biotech companies, Cipla joins the rank of Indian rivals such as Wockhardt and Biocon in a bid to gain from the $90 billion global

Posted in Biotech investment India, General, India Sector Investments | Read More

© Invest in India | Investinindia.com